Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6758
Rank
A$0.96 B
Marketcap
A$48.36
Share price
-1.54%
Change (1 day)
-3.90%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total debt

Total debt on the balance sheet as of June 2025 : A$24.32 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total debt is A$24.32 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Avalon Pharma (Middle East Pharmaceutical) - Total debt on balance sheet (from 2023 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$28.05 M15.47%
2023-12-31A$24.29 M